A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/47 (2006.01) A61K 31/44 (2006.01)
Patent
CA 2427814
Bronchial and respiratory disorders are treated by the separate, sequential, or simultaneous administration of i) an amount of N-(3,5-dichloropyrid-4-yl)- cyclopropylmethoxy-4-difluoromethoxybenzamide, the pyridyl N-oxide thereof, or a pharmaceutically acceptable salt of either compound; and ii) an amount of a leukotriene antagonist, wherein the sum of the first and second amounts is a therapeutically effective amount.
On traite des troubles bronchiques et respiratoires en administrant de manière séparée, séquentielle, ou simultanée i) une quantité de N-(3,5-dichloropyrid-4-yl)-cyclopropylméthoxy-4-difluorométhoxybenzamide, de pyridyle de N-oxyde du composé, ou d'un sel pharmaceutiquement acceptable de l'un de ces composés, et ii) une quantité d'un antagoniste de leucotriène, la somme de la première et de la seconde quantité constituant une dose thérapeutiquement efficace.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
A combination of a pde4 inhibitor and a leukotriene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A combination of a pde4 inhibitor and a leukotriene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A combination of a pde4 inhibitor and a leukotriene... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1400716